Clinical Trials Browser

Phase 3 × EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors × apatinib × Clear all

NCT02824458 2016-07-07

A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations

Phase 3 Unknown

EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors